Member of Sigma Xi, The Scientific Research Honor Society, in recognition of academic achievements and contributions to the advancement of knowledge in the field.

Vice President of the Brazilian Society of Nanomedicine.

Genetic Engineering Auditor – Federal University of Rio Grande do Sul (UFRGS).

Member of the Infectious Diseases Society of America. Participates in the editorial boards of the journals International Journal of Nanomedicine, Pharmaceutics, The Open AIDS Journal, World Journal of Surgical Oncology, Journal of Medical Virology.

CEO of BiotecBrazil – NanoBiotech Solutions, an entrepreneur in the development of human and environmental biological technologies.

Ambassador representing Bentham Science Publishers in Latin America. Member of the Minerva Club for the Promotion of Women in STEM, Polytechnic School of the University of São Paulo (USP).

Postdoctoral researcher at the Polytechnic School (POLI/USP) in Complex Systems Engineering (2016-2021) and Nanotechnologies (2021-2023).

PhD in Sciences – Infectious Diseases, from the Graduate Program in Infectious Diseases at the Federal University of São Paulo (UNIFESP).

Professor of Biotechnologies and Sciences at the University of São Paulo (USP). Holds a Bachelor's degree in Biological Sciences, a Master's degree in Biotechnologies (USP/2002-2004) with an emphasis on biotechnology project economics, immunoderivatives, antibodies, and vaccines at the Butantan Institute.

Develops genome evolution projects, working on evolutionary genomic analysis of complex nonlinear systems, bioinformatics, and nanomedicine, information theory, and viral complexity – HIV, COVID – in collaboration with the Department of Automation and Control of the Polytechnic School at USP and the Department of Retrovirology at UNIFESP.

Participates in the conceptualization, management projects in biotechnology, and systems biology, with an emphasis on vaccinology, nanobiotechnology, and immunogenetics, working in interdisciplinary fields such as microbiology, bioinformatics, recombinant protein development, and evolutionary genomic analysis applied to the design of immunobiologicals, especially in the development and efficacy of nanotechnological vaccines against HIV/coronavirus.

Published Articles in High-Impact Journals

● Can bacteria and carbon-based nanomaterials revolutionize nanoremediation strategies for industrial effluents? Frontiers in Nanotechnology, Volume 6, 2024.

● Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities. International Journal of Nanomedicine, Volume 17, pp. 751-781, 2022.

● Effects of Carbon Nanomaterials and Aloe vera on Melanomas – Where Are We? Recent Updates. Pharmaceutics, Volume 14, p. 2004, 2022.

● Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development. International Journal of Nanomedicine, Volume 16, pp. 5411-5435, 2021.

● Evolutive Temporal Footprint of an HIV-1 Envelope Protein in an Epidemiologically Linked Cluster. The Open AIDS Journal, Volume 14, pp. 41-49, 2020.

● Evidence of genomic information and structural restrictions of HIV-1 PR and RT gene regions from individuals experiencing antiretroviral virologic failure. Infection Genetics and Evolution, Volume 78, p. 1, 2019.

● Impact of antiretroviral resistance and virological failure on HIV-1 informational entropy. Journal of Antimicrobial Chemotherapy, Volume 73, pp. 1054-1059, 2018.

● Advances in Carbon Nanotubes for Malignant Melanoma: A Chance for Treatment. Molecular Diagnosis & Therapy, Volume 22, pp. 703-715, 2018.